Cancer

DYNAMIC-III

The aim of this study is to compare treatment informed by ctDNA results to standard care in patients with stage III colon cancer.

Trial overview

Topic

Bowel cancer

Description

Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Study (DYNAMIC-III).

Eligibility criteria

  • Stage III Colon Cancer.

Study details

The study aims to investigate if taking serial blood samples monitoring for tumour cells can improve treatment for patients curatively treated for colon cancer.

Further information

For more information regarding this clinical trial click here.

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.